Chen, D., Huang, X., Cai, J., Guo, S., Qian, W., Wery, J., & Li, Q. (2015). A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations. Oncotarget.

Chen, Dawei, Xuesong Huang, Jie Cai, Sheng Guo, Wubin Qian, Jean-Pierre Wery, and Qi-Xiang Li. "A Set of Defined Oncogenic Mutation Alleles Seems to Better Predict the Response to Cetuximab in CRC Patient-derived Xenograft Than KRAS 12/13 Mutations." Oncotarget 2015.

Chen, Dawei, et al. "A Set of Defined Oncogenic Mutation Alleles Seems to Better Predict the Response to Cetuximab in CRC Patient-derived Xenograft Than KRAS 12/13 Mutations." Oncotarget 2015.